(March 25 20:30) Forbes.com
We think that Boston Scientific currently is a better pick compared to Illumina. BSX stock trades at about 5.6x trailing revenues, compared to around 18.8x for ILMN. Does this gap in Illumina’s valuation make sense? Actually, to some extent it does, comparing the past performance of these two...
You can find the original article
here